Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction

There are limited treatments currently available for retinal diseases such as age-related macular degeneration (AMD). Cell-based therapy holds great promise in treating these degenerative diseases. Three-dimensional (3D) polymeric scaffolds have gained attention for tissue restoration by mimicking t...

Full description

Bibliographic Details
Main Authors: Maria Abedin Zadeh, Raid G. Alany, Leila Satarian, Amin Shavandi, Mohamed Abdullah Almousa, Steve Brocchini, Mouhamad Khoder
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/5/1330
_version_ 1827740437933195264
author Maria Abedin Zadeh
Raid G. Alany
Leila Satarian
Amin Shavandi
Mohamed Abdullah Almousa
Steve Brocchini
Mouhamad Khoder
author_facet Maria Abedin Zadeh
Raid G. Alany
Leila Satarian
Amin Shavandi
Mohamed Abdullah Almousa
Steve Brocchini
Mouhamad Khoder
author_sort Maria Abedin Zadeh
collection DOAJ
description There are limited treatments currently available for retinal diseases such as age-related macular degeneration (AMD). Cell-based therapy holds great promise in treating these degenerative diseases. Three-dimensional (3D) polymeric scaffolds have gained attention for tissue restoration by mimicking the native extracellular matrix (ECM). The scaffolds can deliver therapeutic agents to the retina, potentially overcoming current treatment limitations and minimizing secondary complications. In the present study, 3D scaffolds made up of alginate and bovine serum albumin (BSA) containing fenofibrate (FNB) were prepared by freeze-drying technique. The incorporation of BSA enhanced the scaffold porosity due to its foamability, and the Maillard reaction increased crosslinking degree between ALG with BSA resulting in a robust scaffold with thicker pore walls with a compression modulus of 13.08 KPa suitable for retinal regeneration. Compared with ALG and ALG-BSA physical mixture scaffolds, ALG-BSA conjugated scaffolds had higher FNB loading capacity, slower release of FNB in the simulated vitreous humour and less swelling in water and buffers, and better cell viability and distribution when tested with ARPE-19 cells. These results suggest that ALG-BSA MR conjugate scaffolds may be a promising option for implantable scaffolds for drug delivery and retinal disease treatment.
first_indexed 2024-03-11T03:24:56Z
format Article
id doaj.art-f8c95bf4dee04546a87156bb517ba76e
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-11T03:24:56Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-f8c95bf4dee04546a87156bb517ba76e2023-11-18T02:50:01ZengMDPI AGPharmaceutics1999-49232023-04-01155133010.3390/pharmaceutics15051330Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related DysfunctionMaria Abedin Zadeh0Raid G. Alany1Leila Satarian2Amin Shavandi3Mohamed Abdullah Almousa4Steve Brocchini5Mouhamad Khoder6Drug Discovery, Delivery and Patient Care (DDDPC) Theme, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames KT1 2EE, UKDrug Discovery, Delivery and Patient Care (DDDPC) Theme, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames KT1 2EE, UKDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 1665659911, Iran3BIO-BioMatter, École Polytechnique de Bruxelles, Université Libre de Bruxelles (ULB), Avenue F.D. Roosevelt, 50-CP 165/61, 1050 Brussels, BelgiumDuba General Hospital, Saudi Ministry of Health, Duba 49313, Saudi ArabiaUCL School of Pharmacy, University College London, London WC1N 1AX, UKDrug Discovery, Delivery and Patient Care (DDDPC) Theme, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames KT1 2EE, UKThere are limited treatments currently available for retinal diseases such as age-related macular degeneration (AMD). Cell-based therapy holds great promise in treating these degenerative diseases. Three-dimensional (3D) polymeric scaffolds have gained attention for tissue restoration by mimicking the native extracellular matrix (ECM). The scaffolds can deliver therapeutic agents to the retina, potentially overcoming current treatment limitations and minimizing secondary complications. In the present study, 3D scaffolds made up of alginate and bovine serum albumin (BSA) containing fenofibrate (FNB) were prepared by freeze-drying technique. The incorporation of BSA enhanced the scaffold porosity due to its foamability, and the Maillard reaction increased crosslinking degree between ALG with BSA resulting in a robust scaffold with thicker pore walls with a compression modulus of 13.08 KPa suitable for retinal regeneration. Compared with ALG and ALG-BSA physical mixture scaffolds, ALG-BSA conjugated scaffolds had higher FNB loading capacity, slower release of FNB in the simulated vitreous humour and less swelling in water and buffers, and better cell viability and distribution when tested with ARPE-19 cells. These results suggest that ALG-BSA MR conjugate scaffolds may be a promising option for implantable scaffolds for drug delivery and retinal disease treatment.https://www.mdpi.com/1999-4923/15/5/1330alginateBSAMaillard reactionage-related-macular degenerationdrug releasefenofibrate
spellingShingle Maria Abedin Zadeh
Raid G. Alany
Leila Satarian
Amin Shavandi
Mohamed Abdullah Almousa
Steve Brocchini
Mouhamad Khoder
Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction
Pharmaceutics
alginate
BSA
Maillard reaction
age-related-macular degeneration
drug release
fenofibrate
title Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction
title_full Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction
title_fullStr Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction
title_full_unstemmed Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction
title_short Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction
title_sort maillard reaction crosslinked alginate albumin scaffolds for enhanced fenofibrate delivery to the retina a promising strategy to treat rpe related dysfunction
topic alginate
BSA
Maillard reaction
age-related-macular degeneration
drug release
fenofibrate
url https://www.mdpi.com/1999-4923/15/5/1330
work_keys_str_mv AT mariaabedinzadeh maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction
AT raidgalany maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction
AT leilasatarian maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction
AT aminshavandi maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction
AT mohamedabdullahalmousa maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction
AT stevebrocchini maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction
AT mouhamadkhoder maillardreactioncrosslinkedalginatealbuminscaffoldsforenhancedfenofibratedeliverytotheretinaapromisingstrategytotreatrperelateddysfunction